Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TroVax + Standard of Care in Advanced Renal Cell Carcinoma
NCT00397345Phase 3Completed
- Sponsor
- Oxford BioMedica
- Start
- Sep 2006
- Primary completion
- Dec 2009
- Modality
- Oncolytic Viruses, Vaccines & Immunotherapeutics
- Countries
- 10
01
Overview
A Phase 3 trial of MVA-5T4 in clear cell renal cell carcinoma (ccRCC), sponsored by Oxford BioMedica. Started Sep 2006; status: completed.
02
Drugs
MVA-5T4
03
Conditions
clear cell renal cell carcinoma (ccRCC)
Beyond the preview
Go deeper on NCT00397345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00397345.